L3VLUP
ProSign in

AMGN in the 13F filings

Amgen Inc · CUSIP 031162100

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Dec 2024
the date the book describes
Filed
5 Nov 2026
latest of these filings; the earliest 4 Feb 2025
Managers listing it
20
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q3 2024 and Q4 2024; 15 listed it in both
Shares listed
31,415,311
combined, among listed positions
Reported value
$8.2bn
combined, at the quarter end

Among the 94 comparable managers: 13 buyers (opened or added shares) and 7 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing AMGN in Q4 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

20 of 20 holders

ActionFiling
Capital World Investors6,495,710$1.7bn0.26%Added+6,029,05813 Feb 2025 (the filing on sec.gov)
Capital Research Global Investors4,890,092$1.3bn0.26%Added+839,68613 Feb 2025 (the filing on sec.gov)
Invesco Ltd3,887,248$1.0bn0.19%Added+270,13513 Feb 2025 (the filing on sec.gov)
Fidelity (FMR LLC)3,686,212$961m0.06%Trimmed-561,0925 Nov 2026 (the filing on sec.gov)
Janus Henderson Group Ltd2,763,903$720m0.37%Trimmed-2,379,42714 Feb 2025 (the filing on sec.gov)
T. Rowe Price Associates Inc2,643,117$689m0.08%Trimmed-1,903,28914 Feb 2025 (the filing on sec.gov)
D. E. Shaw & Co.1,974,213$515m0.38%Added+1,807,76714 Feb 2025 (the filing on sec.gov)
Two Sigma Advisers LP1,545,600$403m0.93%Added+760,70014 Feb 2025 (the filing on sec.gov)
AllianceBernstein LP1,129,122$294m0.10%Trimmed-267,23412 Feb 2025 (the filing on sec.gov)
Two Sigma Investments LP902,286$235m0.51%Added+543,54514 Feb 2025 (the filing on sec.gov)
Voloridge Investment Management LLC393,636$103m0.36%Newnew14 Feb 2025 (the filing on sec.gov)
Woodline Partners LP359,088$94m0.63%Added+51,13814 Feb 2025 (the filing on sec.gov)
Man Group PLC336,503$88m0.23%Added+61,24314 Feb 2025 (the filing on sec.gov)
Holocene Advisors LP227,000$59m0.19%Newnew14 Feb 2025 (the filing on sec.gov)
ARK Investment Management LLC66,374$17m0.14%Trimmed-10,2404 Feb 2025 (the filing on sec.gov)
Tudor Investment Corp59,169$15m0.06%Newnew14 Feb 2025 (the filing on sec.gov)
Eisler Capital Management Ltd34,096$8.8munder 0.1%Newnew14 Feb 2025 (the filing on sec.gov)
Dodge & Cox14,282$3.7munder 0.1%Held013 Feb 2025 (the filing on sec.gov)
PDT Partners LLC5,806$1.5m0.13%Addedn.a.14 Feb 2025 (the filing on sec.gov)
Caxton Associates LLP1,854$483kunder 0.1%Trimmed-3,82014 Feb 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2024 to Q4 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (4)

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
21 in Q3 2024 to 23 in Q2 2026

Tracked managers listing it, at least.

0102030402014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
AMGN by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201321$17.1bnn.a.n.a.
Q3 201319$19.1bnn.a.n.a.
Q4 201322$19.9bnn.a.n.a.
Q1 201417$22.0bnn.a.n.a.
Q2 201424$20.5bnn.a.n.a.
Q3 201427$24.1bnn.a.n.a.
Q4 201424$28.1bnn.a.n.a.
Q1 201526$28.3bnn.a.n.a.
Q2 201528$26.3bnn.a.n.a.
Q3 201532$23.9bnn.a.n.a.
Q4 201531$27.5bnn.a.n.a.
Q1 201629$24.2bnn.a.n.a.
Q2 201628$23.0bnn.a.n.a.
Q3 201631$24.6bnn.a.n.a.
Q4 201625$20.3bnn.a.n.a.
Q1 201731$23.4bnn.a.n.a.
Q2 201725$25.2bnn.a.n.a.
Q3 201725$27.3bnn.a.n.a.
Q4 201726$24.5bnn.a.n.a.
Q1 201824$20.4bnn.a.n.a.
Q2 201820$26.9bnn.a.n.a.
Q3 201819$21.2bnn.a.n.a.
Q4 201820$18.9bnn.a.n.a.
Q1 201928$17.0bnn.a.n.a.
Q2 201922$14.5bnn.a.n.a.
Q3 201926$16.4bnn.a.n.a.
Q4 201921$18.7bnn.a.n.a.
Q1 202021$14.2bnn.a.n.a.
Q2 202020$16.2bnn.a.n.a.
Q3 202016$16.3bnn.a.n.a.
Q4 202019$14.0bnn.a.n.a.
Q1 202116$14.5bnn.a.n.a.
Q2 202123$13.8bnn.a.n.a.
Q3 202124$11.6bnn.a.n.a.
Q4 202121$10.4bnn.a.n.a.
Q1 202223$9.9bnn.a.n.a.
Q2 202228$9.7bnn.a.n.a.
Q3 202221$7.9bnn.a.n.a.
Q4 202224$9.3bnn.a.n.a.
Q1 202322$8.4bnn.a.n.a.
Q2 202326$7.4bnn.a.n.a.
Q3 202326$8.7bnn.a.n.a.
Q4 202324$8.4bn1411
Q1 202425$6.7bn1015
Q2 202420$8.0bn119
Q3 202421$8.8bn165
Q4 202420$8.2bn137
Q1 202525$12.0bn1016
Q2 202520$10.2bn138
Q3 202517$10.4bn89
Q4 202519$18.0bn1322
Q1 202615$21.4bn1715
Q2 202623$24.9bn1913

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

AMGN and GILD →AMGN and ARGX →AMGN and RVMD →Choose a stock to compare with AMGN →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own AMGN, latest filings →Back to the 13F Explorer →